Virtual Booth

My-I-Heart DM Score addresses the need for practical ischemic heart disease risk screening among Malaysian adults with type 2 diabetes. Developed and validated using 31,763 registry patients, it combines a clinical points score with complementary XGBoost artificial intelligence. Routine clinical information supports accessible assessment without additional laboratory investigations. Validation across three cohorts demonstrated consistent discrimination and increasing disease prevalence across risk groups. The innovation could support clinical assessment and referral prioritisation, with potential for institutional licensing and integration into healthcare systems. Further prospective evaluation and broader validation will inform implementation, supporting more equitable cardiovascular care and Sustainable Development Goal 3.